Eve & Co Announces Results of Annual General Meeting

STRATHROY, Ontario, June 25, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) announces the results of its 2021 Annual General Meeting (“AGM”) of shareholders held virtually on Thursday, June 24, 2021. Shareholders approved all the resolutions detailed in the management information circular of the Company dated May 14, 2021 (the “Circular”), namely: Electing all the nominees to the Board of Directors of the Company;Re-appointing Davidson & Company LLP as auditor of the Company for the ensuing year and authorizing the directors to determine the auditor’s compensation; andApproving the Company’s stock option plan for the ensuing year in accordance with the requirements of the TSX Venture Requirements A total of 9,085,059 common shares of the Company were voted at the AGM, representing approximately 31.56% of the issued and outstanding common shares of the Company, with the following results:  Votes For%Withheld%TotalYasir Naqvi as Director8,622,18794.91%462,8725.09%9,085,059Ravi Sood as Director8,614,24094.82%470,8195.18%9,085,059Melinda Rombouts as Director8,616,96094.85%468,0995.15%9,085,059Appointment of Auditor8,776,70296.48%319,9433.52%9,096,645Approval of Stock Option Plan8,598,24894.64%486,8115.36%9,085,059 Following the AGM, the board of directors of the Company confirmed the results of the AGM. ABOUT EVE & CO Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received EU GMP certification. Natural MedCo Ltd. was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 sq. ft. greenhouse located in Strathroy, Ontario. CAUTIONARY NOTES Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s expansion, licensing, the expected increase in production capacity, the expanded product lines, the commencement of shipments to Germany, opportunities for growth, the effects of COVID-19, sales, future strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s management’s discussion and analysis for the three months ended March 31, 2021 which is available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law. Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information, please contact: Melinda RomboutsPresident and Chief Executive OfficerEve & Co IncorporatedTelephone: (855) 628-6337 Rory TaylorInterim Chief Financial OfficerEve & Co IncorporatedTelephone: (855) 628-6337